Intelligent Bio Solutions... (INBS)
1.27
0.00 (0.00%)
At close: Apr 14, 2025, 3:59 PM
1.29
1.57%
After-hours: Apr 14, 2025, 07:53 PM EDT
0.00% (1D)
| Bid | 1.24 |
| Market Cap | 8.62M |
| Revenue (ttm) | 3.03M |
| Net Income (ttm) | -10.69M |
| EPS (ttm) | 0.12 |
| PE Ratio (ttm) | 10.58 |
| Forward PE | 4.11 |
| Analyst | n/a |
| Ask | 1.29 |
| Volume | 64,667 |
| Avg. Volume (20D) | 215,501 |
| Open | 1.30 |
| Previous Close | 1.27 |
| Day's Range | 1.25 - 1.32 |
| 52-Week Range | 1.00 - 3.28 |
| Beta | 4.63 |
About INBS
Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a b...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Dec 23, 2020
Employees 50
Stock Exchange NASDAQ
Ticker Symbol INBS
Website https://gbs.inc
3 weeks ago
-16.59%
Intelligent Bio Solutions shares are trading lower...
Unlock content with
Pro Subscription
1 month ago
-20.45%
Intelligent Bio Solutions shares are trading lower after the company announced a $2.6 million proposed public offering of common stock.
